The Gujarat government has formed a committee to oversee recruitment of manpower for Gujarat Food and Drug Control Administration (FDCA) National Pharmaceutical Pricing Authority (NPPA) cell for effective detection of ceiling price violations in drugs and devices.
A total of seven personnel including a scientific officer will be deputed for the purpose of collection of data on price violations in the state based on the much awaited financial support from the Central Government.
“We have put in place all the necessary infrastructure for the NPPA cell to function. As per the provisions of the law, NPPA headquartered in Delhi will give us certain monetary help for recruitment of manpower for the NPPA cell and is in the process of allocating a budget on the same,” says Dr H G Koshia, Gujarat FDCA Commissioner.
NPPA had discussed and proposed the plan with the state drug regulators to set up a dedicated administrative cell within its office in 2015. While the expenditure related to manpower, amenities and other infrastructural cost will be borne by the Centre, state government will have to provide the space for setting up the office within the state drug regulatory office, as per the plan.
NPPA held a meeting with all the state drug controllers in 2015 in Delhi to set up price monitoring cells in all the states across the country. With the implementation of the plan, violations reported will be dealt timely with the help of the state NPPA cells in case they find any contravention to the provisions of Drug Price Control Order (DPCO-2013).
Through the price monitoring cells, NPPA will closely work with the state drug regulators to find out any discrepancies that affect the consumers. The officials heading the cell will report their findings to the NPPA directly in case they find any pharma company violating the law by selling the drugs above the ceiling price.
Under the proposed scheme, the cell is to be headed by one person along with a team of NPPA officials whose strength will vary as per the size of the pharma industry in the respective states. NPPA has categorised the states based on three categories, i.e. based on maximum, minimum and least number of pharma cos in the state for better division of work.
Maharashtra Food and Drug Administration (FDA) had also given its consent to the NPPA to set up a price monitoring cell in the state for effective detection of drug price violations.